For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221205:nRSE6624Ia&default-theme=true
RNS Number : 6624I Centrica PLC 05 December 2022
Transactions in own shares
Centrica plc
05 December 2022
Centrica plc announces that today it purchased (through UBS AG London Branch)
1,479,413 Centrica plc ordinary shares of 6 (14)/(81) pence each at a price of
95.5815 pence per share. The purchased shares will be held as treasury shares.
Such purchase was effected pursuant to the Company's buyback programme
(details of which were as announced on 15 November 2022) and effected in
accordance with the non-discretionary share repurchase agreement entered into
with UBS AG London Branch, as announced on 15 November 2022.
Since 15 November 2022, Centrica has purchased 21,765,270 ordinary shares at a
cost (excluding dealing and associated costs) of £20,419,262.48.
Following the above purchase, Centrica plc 21,749,589 ordinary shares in
treasury, and has 5,886,096,549 ordinary shares in issue (excluding treasury
shares).
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation) (as in force in the UK and as amended by the Market Abuse
(Amendment) (EU Exit) Regulations 2019), detailed information about the
individual purchases made by UBS AG London Branch is set out below.
Transaction details: Centrica plc ordinary shares of 6 (14)/(81) pence each
Issuer name: Centrica plc
ISIN: GB00B033F229
Intermediary name: UBS AG London Branch
Intermediary Code: UBSWGB2L
Currency: GBP
Aggregated information
Date of purchase: 5 December 2022
Number of ordinary shares purchased: 1,479,413
Highest price paid 96.68p
Lowest price paid 94.68p
Volume weighted average price paid per share (p): 95.5815p
Disaggregated information
The table attached contains detailed information of the individual trades made
by UBS AG London Branch, as part of the buyback programme.
Click on, or paste the following link into your web browser, to view the
associated PDF document.
http://www.rns-pdf.londonstockexchange.com/rns/6624I_1-2022-12-5.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/6624I_1-2022-12-5.pdf)
END
Enquiries:
Investors and Analysts
T: 01753 494900
E: ir@centrica.com
Centrica plc is listed on the London Stock Exchange (CNA)
Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD
Registered in England & Wales number: 3033654
Legal Entity Identifier number: E26EDV109X6EEPBKVH76
ISIN number: GB00B033F229
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSMZMGZNKRGZZM